Does Connecticare Insurance Company, INC. require prior authorization for Myrbetriq?
Connecticare Insurance Company, INC. does not require prior authorization for Myrbetriq on the Medicare Part D plans that cover it.
No covering plan from this payer files a prior-authorization requirement for this drug.
By product strength
| RxNorm product | Plans covering | Require prior auth | Step therapy | Qty limit | Status |
|---|---|---|---|---|---|
| 24 HR mirabegron 25 MG Extended Release Oral Tablet [Myrbetriq]1300797 | 1 / 1 | 0 | 0 | 1 | No prior authorization |
| 24 HR mirabegron 50 MG Extended Release Oral Tablet [Myrbetriq]1300803 | 1 / 1 | 0 | 0 | 1 | No prior authorization |
| 24 HR mirabegron 8 MG/ML Extended Release Suspension [Myrbetriq]2541237 | 1 / 1 | 0 | 0 | 1 | No prior authorization |
Product names come from RxNorm (U.S. National Library of Medicine).
Plan-by-plan detail — 24 HR mirabegron 25 MG Extended Release Oral Tablet [Myrbetriq]
Myrbetriq has 3 products in the corpus; this table is for 24 HR mirabegron 25 MG Extended Release Oral Tablet [Myrbetriq], the one carried on the most plans. The product table above covers every strength.
| Plan | Contract | Tier | Prior auth | Step therapy | Qty limit |
|---|---|---|---|---|---|
| ConnectiCare Choice Dual (HMO-POS D-SNP) | H3276-001 | 3 | No | No | Yes |
- Effective
- 2026-06-30
- Retrieved
- 2026-07-19
- SHA-256
- e626e6bcda1aa6a0071e6f0df6bafe686ae41842cdf0a9feffdc649b6d3ff3ae
We publish the hash of the exact file we ingested so any answer can be audited against the bytes CMS served that day.
Myrbetriq at other payers
Administrative information only. Benefily reports what a payer has published in its own prior-authorization policy as of the effective date shown. It is not medical advice, not a coverage or payment guarantee, and not an authorization. Requirements vary by plan, place of service and member benefits — always verify with the payer before rendering service.